$1.73+0.02 (+1.17%)
Nano-X Imaging Ltd.
Nano-X Imaging Ltd. in the Healthcare sector is trading at $1.73. The stock is currently near its 52-week low of $1.66, remaining 48.0% below its 200-day moving average. Technical signals show neutral RSI of 33 and bearish MACD signal, explaining why NNOX maintains its current current market pressure. The Whystock Score of 35/100 signals elevated caution as indicators diverge.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The co...
Analysts have trimmed Nano-X Imaging's fair value estimate from US$7.75 to US$6.65, a US$1.10 adjustment in the latest update. That change comes alongside a broader reset of key modeling inputs flagged in recent Street research, as analysts reassess how the story fits with their updated assumptions. As you read on, you will see how these shifts feed into the current narrative and what to watch if you want to keep up with future revisions. Analyst Price Targets don't always capture the full...
By Karen Roman Nano-X Imaging Ltd. (Nasdaq: NNOX) said it started two new U.S. collaborations to position its digital tomosynthesis system Nanox.ARC across the country. The first partnership is with Howard Technology Solutions to utilize 300 Nanox.ARC over a period of three years, and the second will deploy the system in clinics and hospitals with […]
Despite a significant net loss, Nano X Imaging Ltd (NNOX) focuses on strategic partnerships and restructuring to drive future growth.
Moby summary of Nano-X Imaging Ltd.'s Q4 2025 earnings call
Nano-X Imaging (NASDAQ:NNOX) executives highlighted new commercial partnerships, manufacturing restructuring actions, and early-stage revenue growth during the company’s fourth quarter 2025 earnings call, while reiterating a full-year 2026 revenue target of $35 million. Commercial partnerships aime